Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Read More > December 1, 2016
Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future Read More > December 1, 2016
Ketamine’s Mechanisms of Rapid Antidepressant Activity: Evidence from Preclinical Studies Read More > November 30, 2016
Psycho-existential distress in cancer patients: A return to “entheogens” Read More > November 30, 2016
Integrative analysis of sex differences in the rapid antidepressant effects of ketamine in preclinical models for individualized clinical outcomes Read More > November 26, 2016
d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology Read More > November 23, 2016
Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant Read More > November 22, 2016
Case series: Antidepressant effects of low-affinity and low-trapping NMDA receptor antagonists did not predict response to ketamine in seven subjects Read More > November 21, 2016
